389
Participants
Start Date
February 6, 2020
Primary Completion Date
September 22, 2023
Study Completion Date
March 31, 2026
SAR408701
Pharmaceutical form: Concentrate for solution for intravenous infusion Route of administration: intravenous (IV) infusion
Docetaxel
Pharmaceutical form: Concentrate for solution for intravenous infusion Route of administration: IV infusion
Investigational Site Number : 0320012, Capital Federal
Investigational Site Number : 0560006, Anderlecht
Investigational Site Number : 3480003, Budapest
Investigational Site Number : 3480007, Budapest
Investigational Site Number : 0560002, Woluwe-Saint-Lambert
Investigational Site Number : 1000004, Sofia
Investigational Site Number : 1000003, Sofia
Investigational Site Number : 6200001, Lisbon
Investigational Site Number : 1000001, Sofia
Investigational Site Number : 0360002, Blacktown
Investigational Site Number : 0360003, Waratah
Investigational Site Number : 0560001, Leuven
Investigational Site Number : 0560003, Liège
Investigational Site Number : 1000007, Plovdiv
Investigational Site Number : 0360001, Woolloongabba
Investigational Site Number : 0320002, Salta
Investigational Site Number : 1000010, Pleven
Investigational Site Number : 3480005, Kaposvár
Investigational Site Number : 1000008, Burgas
Investigational Site Number : 0560005, Ghent
Investigational Site Number : 3800003, Orbassano
Investigational Site Number : 3000005, Athens
Investigational Site Number : 3000001, Athens
Investigational Site Number : 2500001, Marseille
Investigational Site Number : 2500008, Caen
Investigational Site Number : 3800005, Rozzano
Investigational Site Number : 3800001, Milan
Investigational Site Number : 7240009, Madrid / Madrid
Investigational Site Number : 7240002, Madrid
Investigational Site Number : 4100005, Cheongju-si
Investigational Site Number : 7240004, Málaga
Investigational Site Number : 7240006, Pamplona
Investigational Site Number : 2500010, Bordeaux
Florida Cancer Specialists North Division- Site Number : 8400019, St. Petersburg
Florida Cancer Specialists South Division- Site Number : 8400020, Fort Myers
Investigational Site Number : 7920005, Istanbul
Investigational Site Number : 2500013, Montpellier
Investigational Site Number : 7920001, Istanbul
Investigational Site Number : 7920006, Istanbul
Investigational Site Number : 2500003, Rennes
Investigational Site Number : 2500007, Grenoble
Investigational Site Number : 7240011, Seville
Investigational Site Number : 7920014, Kocaeli
Investigational Site Number : 3760002, Kfar Saba
Investigational Site Number : 2500012, Saint-Herblain
Investigational Site Number : 2760002, Essen
Investigational Site Number : 7240008, Valencia
Investigational Site Number : 4100008, Busan
Investigational Site Number : 3800004, Ravenna
Investigational Site Number : 3760003, Petah Tikva
Ca & Hem Center Of W Michigan- Site Number : 8400016, Grand Rapids
Medical College of Wisconsin- Site Number : 8400006, Milwaukee
Investigational Site Number : 3000006, Thessaloniki
Investigational Site Number : 2760001, Heidelberg
Investigational Site Number : 2500009, Pierre-Bénite
Investigational Site Number : 3000003, Heraklion
Investigational Site Number : 6420012, Otopeni
Investigational Site Number : 2500011, Paris
Investigational Site Number : 2500014, Paris
Renovatio Clinical - Site Number : 8400013, The Woodlands
Renovatio Clinical- Site Number : 8400032, El Paso
Investigational Site Number : 2500006, Créteil
Investigational Site Number : 2500002, Saint-Mandé
Investigational Site Number : 2500004, Villejuif
Investigational Site Number : 1560026, Beijing
Investigational Site Number : 6430001, Moscow
Investigational Site Number : 1560009, Changchun
Investigational Site Number : 1560010, Changchun
Investigational Site Number : 1560005, Harbin
Investigational Site Number : 6430003, Saint Petersburg
Investigational Site Number : 1560023, Nanjing
Investigational Site Number : 1560019, Nanjing
Investigational Site Number : 1560047, Jinan
Investigational Site Number : 1560045, Tianjin
Investigational Site Number : 6420005, Timișoara
Investigational Site Number : 7020001, Singapore
Investigational Site Number : 1560025, Hangzhou
Investigational Site Number : 1560033, Hangzhou
Investigational Site Number : 1560021, Hangzhou
Investigational Site Number : 1560011, Hangzhou
Investigational Site Number : 7020002, Singapore
Investigational Site Number : 1560024, Fuzhou
Investigational Site Number : 1560044, Chongqing
Investigational Site Number : 1560043, Chongqing
Investigational Site Number : 6420010, Cluj-Napoca
Investigational Site Number : 6420011, Cluj-Napoca
Investigational Site Number : 1560015, Changsha
Investigational Site Number : 1560039, Changsha
Investigational Site Number : 1560006, Wuhan
Investigational Site Number : 1560041, Zhengzhou
Investigational Site Number : 1560040, Zhengzhou
Investigational Site Number : 6420009, Brasov
Investigational Site Number : 6420008, Alba Iulia
Investigational Site Number : 1560001, Guangzhou
Investigational Site Number : 1560036, Guangzhou
Investigational Site Number : 1560037, Guangzhou
Investigational Site Number : 1560017, Guangzhou
Investigational Site Number : 1560050, Huizhou
Investigational Site Number : 1560016, Zhanjiang
Investigational Site Number : 1560012, Nanning
Investigational Site Number : 1560032, Chengdu
Investigational Site Number : 1560038, Chengdu
Investigational Site Number : 1520001, Viña del Mar
Investigational Site Number : 3760001, Haifa
Investigational Site Number : 1520007, Santiago
Investigational Site Number : 1520006, Santiago
Investigational Site Number : 1520009, Santiago
Investigational Site Number : 1520002, Santiago
Roswell Park Cancer Institute Site Number : 8400011, Buffalo
Lankenau Hospital Cancer Center- Site Number : 8400017, Wynnewood
Investigational Site Number : 0320009, CABA
Investigational Site Number : 0320003, Viedma
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 0320004, Buenos Aires
Investigational Site Number : 0320014, Córdoba
Investigational Site Number : 0560004, Edegem
Centro Regional Integrado De Oncologia - CRIO- Site Number : 0760002, Fortaleza
~Instituto De Oncologia Parana- Site Number : 0760008, Curitiba
Centro Avancado de Oncologia CECAN - Liga Contra o Cancer- Site Number : 0760026, Natal
Clínica de Oncologia Reichow Site Number : 0760023, Blumenau
Hospital de Base Sao Jose do Rio Preto Site Number : 0760001, São José do Rio Preto
Hospital Sirio Libanes- Site Number : 0760018, São Paulo
Investigational Site Number : 1240003, Greenfield Park
Investigational Site Number : 1240010, Montreal
Investigational Site Number : 3000004, Ioannina
Investigational Site Number : 3800006, Catania
Investigational Site Number : 7920007, Izmir
Investigational Site Number : 7920010, Izmir
Investigational Site Number : 7920009, Malatya
Investigational Site Number : 3920002, Nagoya
Investigational Site Number : 3920015, Nagoya
Investigational Site Number : 3920012, Fukuoka
Investigational Site Number : 3920008, Kurume-shi
Investigational Site Number : 3920016, Sapporo
Investigational Site Number : 3920017, Himeji-shi
Investigational Site Number : 3920006, Kanazawa
Investigational Site Number : 3920005, Yokohama
Investigational Site Number : 3920009, Natori-shi
Investigational Site Number : 3920001, Hirakata-shi
Investigational Site Number : 3920003, Osaka
Investigational Site Number : 3920013, Osaka Sayama-shi
Investigational Site Number : 3920004, Sunto-gun
Investigational Site Number : 3920011, Bunkyo-ku
Investigational Site Number : 3920018, Mitaka-shi
Investigational Site Number : 3920007, Wakayama
Investigational Site Number : 3920010, Ube-shi
Investigational Site Number : 4840003, Cuauhtémoc
Investigational Site Number : 5280003, 's-Hertogenbosch
Investigational Site Number : 5280004, Breda
Investigational Site Number : 5280005, Utrecht
Investigational Site Number : 6160004, Olsztyn
Investigational Site Number : 6160001, Warsaw
Investigational Site Number : 6200002, Almada
Investigational Site Number : 6200004, Lisbon
Investigational Site Number : 6200005, Porto
Investigational Site Number : 6200006, Porto
Investigational Site Number : 6420003, Bucaresti
Investigational Site Number : 4100006, Seoul
Investigational Site Number : 4100007, Seoul
Investigational Site Number : 4100003, Seoul
Investigational Site Number : 4100004, Seoul
Investigational Site Number : 4100001, Seoul
Investigational Site Number : 7240007, Barcelona
Investigational Site Number : 7240005, Barcelona
Investigational Site Number : 7240001, L'Hospitalet de Llobregat
Investigational Site Number : 7920008, Adana
Investigational Site Number : 7920012, Adana
Investigational Site Number : 7920002, Adana
Investigational Site Number : 7920011, Ankara
Lead Sponsor
Sanofi
INDUSTRY